Summary
Receptor assay results were compared with the ultrastructure of 127 breast cancers (112 primary tumors, six recurrent lesions, nine metastases). Tumors were considered to be receptor positive if the receptor levels were ⩾ 15 fmol/mg of soluble tissue protein. Most breast cancer had heterogenous cells with different grades of ultrastructural differentiation. A prevalence of well-differentiated cancer cells and an abundance of intracytoplasmic vacuoles had a significant correlation with a positive estrogen receptor status. The correlation was better than between malignancy grades and receptor content. The type of breast cancer and the menopausal status bore no relation to receptor content. Progesterone receptors were found in well-differentiated tumors of low malignancy.
Similar content being viewed by others
References
Black MM, Speer FD, Opler SR (1956) Structural representation of tumor-host relationships in mammary carcinoma. Biologic and prognostic significance. Am J Clin Pathol 26: 250–265
Bloom HJ, Richardson WW (1957) Histological grading and prognosis in breast cancer. Br J Cancer 11: 359–377
Fisher ER, Liu CK, Rockette H, Fisher B (1980) Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer. Cancer 45: 349–353
Heuson JC, Leclerq G, Lengeval E, Deboel MC, Mettheiem WH, Heimenn R (1975) Estrogen receptors: Prognostic significance in breast cancer. In: McGuire WL, Carbone PP, Vollmer EP (eds) Estrogen receptors in human breast cancer. Raven Press, New York, pp 57–70
Jensen EV, Smith S, de Sombre ER (1976) Hormone dependency in breast cancer. J Steroid Biochem 7: 911–917
Jungblut PW, Hätzel I, de Sombre ER, Jensen EV (1967) Über Hormon-„Rezeptoren“. Die östrogenbindenden Prinzipien der Erfolgsorgane. 18. Colloquium der Gesellschaft für Physiologische Chemie vom 5. bis 8. April 1967 in Mosbach/Baden. Springer, Berlin Heidelberg New York
Knight WA, Livingston BR, Gregory EJ, McGuire WL (1977) Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37: 4669–4671
Lesser ML, Rosen PP, Senie RT, Duthie K, Menendez-Botet C, Schwartz M (1981) Estrogen and progesterone receptors in breast carcinoma: Correlations with epidemiology and pathology. Cancer 48: 299–309
Maillot K von, Egger H, Horke W, Prestele H (subm. for public.) Die Korrelation des Steroidrezeptorstatus zu histomorphologischen Kriterien und der Prognose des operierten Mammacarcinoms. Arch Gynecol
Maillot K von, Gentsch HH, Gunselmann W (1980) Steroid receptors and response to endocrine treatment and chemotherapy of advanced breast cancer. J Cancer Res Clin Oncol 98: 301–313
Maillot K von, Horke W, Prestele H (1982) Prognostic significance of the steroid receptor content in primary breast cancer. Arch Gynecol 231: 1852–190
Maas H, Engel B, Trams G (1975) Steroid hormone receptors in human breast cancer and the clinical significance. J Steroid Biochem 6: 743–749
McGuire WL, Carbone PP, Sears ME, Escher GC (1974) Estrogen receptors in human breast cancer. An overview. In: McGuire WL, Carbone PP, Vollmer EP (eds) Estrogen receptors in human breast cancer. Raven Press, New York, pp 1–7
Rosen PP, Menendez-Botet CJ, Senie RT, Schwartz MK, Schottenfeld D, Farr GH (1978) Estrogen receptor protein and the histopathology of human mammary carcinoma. In: McGuire WL (ed) Hormones, receptors and breast cancer. New York, Raven Press, pp 71–83
Stegner HE, Trams G, Pape C (1980) Estrogen receptors and ultrastructural pathology of mammary carcinoma. In: Dallenbach-Hellweg G (ed) Functional morphologic changes in female sex organs induced by exogenous hormones. Springer, Berlin Heidelberg New York, pp 221–228
Walker RA, Cove DH, Howell A (1980) Histological detection of estrogen receptor in human breast carcinomas. Lancet 1: 171–173
Author information
Authors and Affiliations
Additional information
Supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 118-B12)
Rights and permissions
About this article
Cite this article
Tulusan, A.H., Hamann, M., Prestele, H. et al. Correlations of the receptor content and ultrastructure of breast cancer cells. Arch. Gynecol. 231, 177–184 (1982). https://doi.org/10.1007/BF02110116
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02110116